Antigen-presenting cell engineering. The molecular toolbox.

M L Tykocinski, D R Kaplan, M E Medof

Abstract readReview

In one paragraph

Review in The American journal of pathology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it

0cells of the map it votes in

6citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters.Biomolecules · 2023
Review
Targeting the B7 family of co-stimulatory molecules: successes and challenges.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2013
Review
Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.Immunotherapy · 2010
Review
New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.Immunologic research · 2003
Review
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.The American journal of pathology · 1997
Article
Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.The American journal of pathology · 1996
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M L TykocinskiDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.

D R Kaplan

M E Medof

Funding

ROLE OF DAF IN THE COMPLEMENT CASCADE ND IN PNHR01AI023598 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MEDOF, MELVIN EDWARD · 1985 to 2009

$3.8M

ENGINEERING ARTIFICIAL VETO CELLSR01AI031044 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI TYKOCINSKI, MARK L · 1992 to 2006

$2.6M

STRUCTURE AND FUNCTION OF GLYCOINOSITOLP01DK038181 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI TARTAKOFF, ALAN MICHAEL · 1987 to 1996

–

NIAID NIH HHS R01 AI23598NIAID NIH HHS R01 AI31044NIDDK NIH HHS P01 DK38181

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigen-Presenting CellsGenetic EngineeringImmunotherapyGenetic TherapyHumansNeoplasmsProtein Engineering

Identifiers

PMID8546197

PMCPMC1861622

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.